ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 95 | ESPE2022 | Next issue

60th Annual ESPE (ESPE 2022)

Rome, Italy
15 Sept 2022 - 17 Sept 2022

Card image cap
The 60th ESPE Annual Meeting will now be taking place in Rome, Italy.

Poster Category 1

Diabetes and Insulin

Previous section
Bone, Growth Plate and Mineral Metabolism
Table of contents
Next section
Fat, Metabolism and Obesity

hrp0095p1-34 | Diabetes and Insulin

Early treatment of neonatal diabetes with oral glibenclamide suspension (Amglidia®) in an extremely preterm infant: evidence for efficacy, safety and easiness.

hrp0095p1-35 | Diabetes and Insulin

Does parental food choice preferences impact on metabolic control of children with type 1 diabetes?

hrp0095p1-36 | Diabetes and Insulin

Human umbilical cord derived mesenchymal stem cells alleviate T1DM model via TGFBI-mediated T cells proliferation

hrp0095p1-37 | Diabetes and Insulin

The role of insulin resistance and pancreatic β-cell dysfunction in the development of prediabetes in obese adolescents

hrp0095p1-38 | Diabetes and Insulin

Severe clinical presentation of congenital hyperinsulinism due to newly discovered mutation of HK1: case report

hrp0095p1-39 | Diabetes and Insulin

Case report: Suppression of gonadotropins with contraceptives in type A insulin resistance ameliorates virilizing insulin-induced hyperandrogenism

hrp0095p1-40 | Diabetes and Insulin

Pancreatic Shear Wave Elastography in Children with T1D; Relation to Functional B cell mass Pancreatic Reserve

hrp0095p1-41 | Diabetes and Insulin

A Rare Cause in Childhood: Mody 11

hrp0095p1-42 | Diabetes and Insulin

Symptoms and Glycemic Control in Young People with Type 1 Diabetes following SARS-CoV-2 Infection: an Observational Study

hrp0095p1-43 | Diabetes and Insulin

The spectrum of paediatric diabetes subtypes from a single center in a highly consanguineous region

hrp0095p1-44 | Diabetes and Insulin

Characterisation of Type 2 Diabetes mellitus in children and young people across 2 large tertiary Paediatric Diabetes centres

hrp0095p1-45 | Diabetes and Insulin

Non-insulin-dependent diabetes mellitus due to a variant in MAPK8IP1: a case report

hrp0095p1-46 | Diabetes and Insulin

The incidence of Type 1 diabetes mellitus has stopped falling and is rising again in Ireland – a preliminary report from the Irish Childhood Diabetes National Register

hrp0095p1-47 | Diabetes and Insulin

Congenital hyperinsulinism: a case with a missense monoallelic heterozygous ABCC8 mutation responsive partially to diazoxide therapy

hrp0095p1-48 | Diabetes and Insulin

Maternal Hepatic HKDC1 Expression Impacts Offspring Glucose Metabolism

hrp0095p1-49 | Diabetes and Insulin

Impact of Metabolic-associated fatty liver disease (MAFLD) on the Cholesterol efflux capacity of High-density lipoproteins in adolescents with type 2 Diabetes

hrp0095p1-50 | Diabetes and Insulin

An Evaluation of MiniMed™ 780G System Performance in Childhood: A Single Center Experience from Turkey

hrp0095p1-51 | Diabetes and Insulin

Health-related quality of life and metabolic control in children and young patients with type 1 diabetes and in their parents before and after the COVID-19 lockdown.

hrp0095p1-52 | Diabetes and Insulin

Relationship between the quantification of physical activity according to the PAQ-c survey and the metabolic control of pediatric patients with type 1 diabetes.

hrp0095p1-53 | Diabetes and Insulin

One Case Report of MODY5 with MCPH3

hrp0095p1-54 | Diabetes and Insulin

Relation between body weight and bone mineral density in type 1 diabetic patients

hrp0095p1-55 | Diabetes and Insulin

Screening for disordered eating behaviours and associated factors in children and adolescents with type 1 diabetes

hrp0095p1-56 | Diabetes and Insulin

Curative effect contributors of exercise in type one diabetes: Irisin and Sestrin

hrp0095p1-57 | Diabetes and Insulin

Implications of parental anxiety, and fear of Hypoglycemia in glucose control of their Children with Type 1 Diabetes

hrp0095p1-58 | Diabetes and Insulin

Developing a digital Southeast Asia Type 1 diabetes healthcare educational platform in local languages during the pandemic

hrp0095p1-59 | Diabetes and Insulin

Type 1 diabetes glycated haemoglobin outcomes did not differ by insulin regimen in two large Cambodian tertiary hospitals

hrp0095p1-60 | Diabetes and Insulin

Prevalence of Autoimmunity in Relatives of Patients with Type 1 Diabetes: Time to The Clinical Onset of Diabetes and Associated Risk Factors

hrp0095p1-61 | Diabetes and Insulin

Increased incidence of childhood type 1 diabetes during COVID-19 pandemic. Figures from an Italian tertiary care center

hrp0095p1-62 | Diabetes and Insulin

A rare case of concomitant inflammatory polyneuropathy and type 1 diabetes with Covid 19 in a teenager

hrp0095p1-233 | Diabetes and Insulin

Effects of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Modulating Therapy on Glucose Metabolism in Cystic Fibrosis Patients

hrp0095p1-234 | Diabetes and Insulin

Paediatric Post-Prandial Hyperinsulinaemic Hypoglycaemia

hrp0095p1-235 | Diabetes and Insulin

Etiology-based diagnosis of pediatric patients with atypical diabetes using routine and omic-based phenotyping and genotyping: results from the GENEPEDIAB study

hrp0095p1-236 | Diabetes and Insulin

A novel homozygous mutation in the Glycerol-3-Phosphate Dehydrogenase 1 gene combined with a heterozygous mutation in the Glucokinase Regulator gene associated with hyperglycaemia, hypertriglyceridaemia and non-alcoholic fatty liver in a 17 year old woman

hrp0095p1-237 | Diabetes and Insulin

Neurodevelopmental outcomes in children with congenital hyperinsulinism.

hrp0095p1-238 | Diabetes and Insulin

Faster-acting insulin Fiasp vs insulin Novorapid in type 1 diabetes children and adolescents with sensor-augmented pump therapy

hrp0095p1-239 | Diabetes and Insulin

Why understanding hemoglobin glycated measurement can be important: Santa Juana hemoglobin variant and falsely elevated HbA1c

hrp0095p1-240 | Diabetes and Insulin

Successful inpatient use of a fully closed-loop (FCL) insulin delivery system in an adolescent with diabetes secondary to pancreatitis

hrp0095p1-241 | Diabetes and Insulin

3 Screen ICA TM Elisa - A New Tool for Identify Pre-Clinical Diabetes in First-Degree Relatives of Patients with Type 1 Diabetes (Pre-D1Abetes Study)

hrp0095p1-242 | Diabetes and Insulin

The lncOb rs10487505 polymorphism impairs insulin sensitivity and glucose tolerance in children and adolescents with obesity

hrp0095p1-243 | Diabetes and Insulin

Did Covid-19 pandemic restrictions impact on diabetic care of children and adolescents in Armenia?

hrp0095p1-244 | Diabetes and Insulin

Glycemic Outcomes and Safety During the MiniMed™ 780G Advanced Hybrid Closed-Loop System in Egyptian Patients with Type 1 Diabetes

hrp0095p1-245 | Diabetes and Insulin

Analysis of peripheral nerve conduction function and its influencing factors in children and adolescents with type 1 diabetes mellitus

hrp0095p1-246 | Diabetes and Insulin

Developmental surveillance in children with Congenital Hyperinsulinism (CHI) - Personalising care

hrp0095p1-247 | Diabetes and Insulin

Monogenic diabetes clinic: 3-year experience

hrp0095p1-248 | Diabetes and Insulin

Carbohydrate counting efficacy in glycaemic control among children and adolescents with type 1 diabetes mellitus: a systematic review and meta-analysis

hrp0095p1-249 | Diabetes and Insulin

Glycemic control and complications of type 2 diabetes mellitus in children and adolescents during the COVID-19 outbreak

hrp0095p1-250 | Diabetes and Insulin

The Metabolic Syndrome is frequent in Children and Adolescents with Type 1 Diabetes Compared to Healthy Controls

hrp0095p1-251 | Diabetes and Insulin

Does the Diagnosis of Type 1 Diabetes Affect Only Diabetics? What About Family?

hrp0095p1-252 | Diabetes and Insulin

Novel insights on the associations between specific brain tract segmental alterations, glucose levels, and cognitive performance among adolescents with type 1 diabetes

hrp0095p1-253 | Diabetes and Insulin

Incidence and risk factors for paediatric diabetic retinopathy: case control for a tertiary hospital in Leeds, United Kingdom

hrp0095p1-254 | Diabetes and Insulin

Auxological parameters and metabolic control in children and young patients with type 1 diabetes 1-year after COVID-19 pandemic.

hrp0095p1-255 | Diabetes and Insulin

Initial results in the initiation of the hybrid closed-loop system in Spanish children with type 1 diabetes mellitus

hrp0095p1-256 | Diabetes and Insulin

Analysis of NGS panel examination in patients suspected of MODY in a single tertiary hospital

hrp0095p1-257 | Diabetes and Insulin

A novel mutation in INS gene in an infant with neonatal diabetes mellitus: A case report and functional study

hrp0095p1-258 | Diabetes and Insulin

Effect of Multidisciplinary Intervention on Emotional and Behavioral profile in Children with Type 1 Diabetes Mellitus: An Interventional Longitudinal study

hrp0095p1-259 | Diabetes and Insulin

Tear Proteomics in Children and Adolescents with Type 1 Diabetes Mellitus and Correlation with Cognitive Function Levels

hrp0095p1-260 | Diabetes and Insulin

The association between Epilepsy and Diabetes mellitus diagnosed before 2 years of age

hrp0095p1-261 | Diabetes and Insulin

Parental stress in children with type 1 diabetes from different socioeconomic backgrounds

hrp0095p1-434 | Diabetes and Insulin

Role of glucose variability on linear growth in children with Type 1 Diabetes

hrp0095p1-435 | Diabetes and Insulin

Are we sure that the prevalence of SARS-CoV-2 infection is not underestimated? Usefulness of serological antibodies assays in children and adolescents with type 1 diabetes

hrp0095p1-436 | Diabetes and Insulin

Association of the apoptotic markers Apo1/Fas and cCK-18 and the adhesion molecule ICAM-1 with Type 1 diabetes mellitus in children and adolescents.

hrp0095p1-437 | Diabetes and Insulin

The Relationship between Visceral Adipose Index and Metabolic Syndrome in Children with Type 1 Diabetes Mellitus

hrp0095p1-438 | Diabetes and Insulin

Abstract unavailable

hrp0095p1-439 | Diabetes and Insulin

Deciphering Monogenic Diabetes Mellitus in Spanish Pediatric Patients: A Cross-Sectional Study

hrp0095p1-440 | Diabetes and Insulin

Abstract unavailable

hrp0095p1-441 | Diabetes and Insulin

NEUROD1 mutation as a cause of neonatal diabetes: the rarest of the rare!

hrp0095p1-442 | Diabetes and Insulin

A Continuous Quality Improvement Effort Implemented by The Italian Network of Pediatric Diabetes Clinics

hrp0095p1-443 | Diabetes and Insulin

Co-segregation analysis and functional trial in vivo of candidate genes for monogenic diabetes

hrp0095p1-444 | Diabetes and Insulin

Influence of Family Status and Living Circumstances on Metabolic Control in Patients with Type 1 Diabetes

hrp0095p1-445 | Diabetes and Insulin

Glucagon Response to Hypoglycemia During Extended Oral Glucose Tolerance Test in Children with Cystic Fibrosis and Comparing with Healthy Peers

hrp0095p1-446 | Diabetes and Insulin

Case Report: LRBA deficiency related Monogenic Neonatal Diabetes Mellites

hrp0095p1-447 | Diabetes and Insulin

Access and use of new technologies in diabetes care in patients that need an Interpreter compared to those that do not

hrp0095p1-448 | Diabetes and Insulin

The effect of physical activity on leptin and adiponectin in youth with T1D

hrp0095p1-449 | Diabetes and Insulin

Do-It-Yourself Artificial Pancreas Systems in a PediatricPopulation with Type 1 Diabetes in a Real-life Setting: The AWeSoMe Study Group Experience

hrp0095p1-450 | Diabetes and Insulin

Unstable glycaemia in rare, early-onset Shwachman-Diamond syndrome-associated diabetes mellitus

hrp0095p1-451 | Diabetes and Insulin

Maintaining insulin and medical supplies for disadvantaged people with Type 1 Diabetes in Southeast Asia during the COVID-19 pandemic

hrp0095p1-452 | Diabetes and Insulin

Limited genotype-phenotype correlation in FOXP3 gene within same family member

hrp0095p1-453 | Diabetes and Insulin

Usability of CGM for hyperglycemia detection during systemic glucoriticoid treatment.

hrp0095p1-454 | Diabetes and Insulin

Clinical and genetic evaluation of patients with maturity onset diabetes of the young (MODY) : Single center experience

hrp0095p1-455 | Diabetes and Insulin

An Adolescent with HNF1B Deletion. A Case Report

hrp0095p1-456 | Diabetes and Insulin

Outmoded by Mody? A Case Report of HNF1A-Mody in Paediatric Stroke

hrp0095p1-457 | Diabetes and Insulin

Rabson Mendenhall Syndrome: A Rare Insulin Resistance Syndrome

hrp0095p1-458 | Diabetes and Insulin

BMI in Bulgarian children and adolescents with type 1 diabetes mellitus – data of two national cross-sectional studies

hrp0095p1-459 | Diabetes and Insulin

Usefulness of glycated albumin level as a glycemic index complementing glycosylated hemoglobin in children and adolescents

hrp0095p1-460 | Diabetes and Insulin

Assessing the clinical effectiveness of advanced hybrid closed loop insulin pump therapy and calibration-free glucose sensor - experience of a single centre, Arendal, Norway

hrp0095p1-461 | Diabetes and Insulin

Risks and Metabolic Consequences of Ramadan Fasting on Egyptian Adolescents With Type 1 Diabetes Mellitus

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more